Myung In Pharmaceutical LTD. (KRX:317450)
42,450
+350 (0.83%)
At close: Nov 19, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 619.77 billion as of November 19, 2026. It is the 14,582nd most valuable company in the world and the 368th biggest in South Korea. Its market cap has decreased by 37.57% in one year.
Market Cap
619.77B
Enterprise Value
150.75B
Revenue
293.03B
Global Rank
Country Rank
#368 South Korea
PE Ratio
6.60
ChartMarket Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 619.77B, a decrease of -65.18%. That is a compound annual growth rate of -60.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 619.77B | -38.39% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.38T |
| Celltrion | 48.66T |
| ALTEOGEN | 12.05T |
| Samsung Epis Holdings | 8.99T |
| Chabiotech | 696.54B |
| Daewoong | 685.62B |
| Komipharm International | 598.76B |
| Dong-A Pharmaceutical | 595.59B |